https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual
results to differ materially from those expressed in or implied by the forward-looking statements.
Use of Non GAAP Measures
Page 3
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500
Strategy and Execution Drive Results
Page 4
All time closing high of
$29.48
August 1, 2013
• 15 consecutive quarters of
double digit EPS growth
• 42% CAGR adjusted EPS
expansion 2006-2012
• YTD stock price has
increased 42% versus 20%
growth in the S&P
400% increase in market cap,
from $0.7b to $2.8b since
2006
The World’s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Four Pillar Strategy
Page 5
PP&S
15%
Specialty
60%
Distribution
25%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010* 2011* 2012* 2015
Target
A
dj
us
te
d
Ea
rn
in
gs
P
er
S
ha
re
Appliance
6%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
4%
Consumer
9%
Packaging
18%
Industrial
10%
Misc.
5%
HealthCare
9%
Transportation
16%
Textiles
1%
United
States
70%
Europe
14%
Canada
8%
Asia
5%
Latin
America
3%
2012 Revenues: $4.0 Billion*
End Markets*
2012 Revenues: $4.0 Billion*
EPS
Page 6
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations
PolyOne
At A Glance
* Restated to exclude discontinued operations
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
**Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes discontinued operations
2%
34%
43% 45%
60% 62%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2012 2012 PF** H1'13 2015
%
o
f O
pe
ra
ti
ng
In
co
m
e*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $87M $114M $150M $98M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 H1 2013 2015
Where we were Where we are Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.6% 12 – 16%
Global Specialty Engineered
Materials 1.1% 9.2% 12 – 16%
Designed Structures & Solutions -- 4.4% 8 – 10%
Performance Products &
Solutions 5.4% 8.3% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 26%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
*Percentage of Specialty Platform revenue from products introduced in last five years
11.5%
46.5%
2006 Q2 2013
$20.3
$44.7
2006 TTM
Q2'13
14.3%
31.1%
2006 Q2 2013
Research & Development
Spending
Specialty Platform
Vitality Index Progression*
Innovation Drives Earnings Growth
($ millions)
Specialty Platform
Gross Margin %
Page 9
We are Experts in Polymer Science and Formulation
Polymer Science
Formulation
Chemistry
Processing
Inputs
Base Resins
Additives
Modifiers
Colorants
Specialized
Polymer Materials,
Services, and Solutions
Expertise
Satisfied
Consumers
PolyOne Customer
Innovative
Products & Services
Marketplace Demands
Performance Requirements
Value Drivers
Page 10
Positioned for Strong Growth
2015 Target
Rev: $5B
Adj.
Senior management uses adjusted operating income, adjusted EPS, and working
capital to assess performance and allocate resources because senior management believes that these measures are useful in
understanding current profitability levels and that current levels may serve as a base for future performance.
https://www.avient.com/sites/default/files/resources/Credit%2520Suisse%2520June%252026%25202013.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual
results to differ materially from those expressed in or implied by the forward-looking statements.
Use of Non GAAP Measures
Page 3
-150.00%
-100.00%
-50.00%
0.00%
50.00%
100.00%
150.00%
200.00%
250.00%
300.00%
350.00%
PolyOne S&P 500
Strategy and Execution Drive Results – Since 2006:
Page 4
All time closing high of
$26.63
May 28, 2013
• 14 consecutive quarters of
double digit EPS growth
• 380 basis point increase in
return on sales
• 300% share price
expansion
• 300% increase in total
shareholder return
• 42% CAGR EPS expansion
• $1.8 billion increase in
market cap
• Track record of successful
acquisitions
The World’s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Four Pillar Strategy
Page 5
2013 Portfolio Transformation Highlights
• Substantial organic mix improvement drives 29% increase in
first quarter EPS – 14th consecutive quarter of double-digit
EPS growth
• Completed acquisition of Spartech
• Announced the creation of a new Specialty segment –
Designed Structures and Solutions
• Completed the sale of our non-core resin
assets
• Realigned our Specialty Coatings
business into our GCAI segment
Page 6
PP&S
15%
Specialty
60%
Distribution
25%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010* 2011* 2012* 2015
Target
A
dj
us
te
d
Ea
rn
in
gs
P
er
S
ha
re
Appliance
6%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
4%
Consumer
9%
Packaging
18%
Industrial
10%
Misc.
5%
HealthCare
9%
Transportation
16%
Textiles
1%
United
States
70%
Europe
14%
Canada
8%
Asia
5%
Latin
America
3%
2012 Revenues: $4.0 Billion*
End Markets*
2012 Revenues: $4.0 Billion*
EPS
Page 7
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations
PolyOne
At A Glance
* Restated to exclude discontinued operations
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
**Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes resin assets
2%
34%
43% 45%
60%
65 –
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2012 2012PF** 2015
%
o
f O
pe
ra
ti
ng
In
co
m
e*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $87M $114M $150M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 8
2007 Q1 2013 2015
Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 4.6% 11.7% 12 – 16%
Global Specialty Engineered
Materials
1.3% 10.1% 12 – 16%
Designed Structures & Solutions -- 4.6% 8 – 10%
Performance Products &
Solutions
6.1% 8.1% 9 – 12%
Distribution 3.0% 6.0% 6 – 7.5%
2) Specialty Platform % of
Operating Income
20% 60% 65 – 75%
3) ROIC* (after-tax) 7% 9.2% 15%
4) Adjusted EPS Growth N/A 29%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 9
*Percentage of Specialty Platform revenue from products introduced in last five years
19.5%
50.0%
2006 Q1 2013
$20.3
$41.9
2006 2012
14.3%
27.8%
2006 Q1 2013
Research & Development
Spending
Specialty Platform
Vitality Index Progression*
Innovation Drives Earnings Growth
($ millions)
Specialty Platform
Gross Margin %
Page 10
We are Experts in Polymer Science and Formulation
Polymer Science
Formulation
Chemistry
Processing
Inputs
Base Resins
Additives
Modifiers
Colorants
Specialized
Polymer Materials,
Services, and Solutions
Expertise
Satisfied
Consumers
PolyOne Customer
Innovative
Products & Services
Marketplace Demands
Performance Requirements
Value Drivers
Page 11
Positioned for Strong Growth
2015 Target
Rev: $5B
Adj.
Senior management uses adjusted operating
income, adjusted EPS, and working capital to assess performance and allocate resources because senior
management believes that these measures are useful in understanding current profitability levels and that
current levels may serve as a base for future performance.
https://www.avient.com/sites/default/files/resources/TPE_Overmolding_Solutions_for_Engineering_Thermoplastics.pdf
The adhesion is categorized based on
adhesive failure (A)- if no TPE residue is left on the substrate, or cohesive failure
(C)- if the failure is in TPE.
Based on adhesion strength required by the consumer we have
categorized an adhesion value higher than 13 pli to be acceptable for adhesion.
TPE materials are quantified based on Shore hardness, which is a materials
resistance to indenture on a 6.3-mm minimum thickness molded plaque (ASTM
D2240).
https://www.avient.com/sites/default/files/2022-08/Humotech Robotic Prosthetic Case Study.pdf
Humotech is currently working with the
US Department of Defense, US Department of Veterans
Affairs, and others to develop, evaluate, and validate
this emulator-based test-drive strategy.
https://www.avient.com/sites/default/files/2022-04/Edgetek PKE Processing Guide.pdf
Duration 2–3 Hours
Moisture Level
Allowable N/A
Notes
These preliminary guidelines are based on lab results.
https://www.avient.com/sites/default/files/2020-11/eccoh-processing-guide.pdf
ECCOH™ LSFOH
LOW SMOKE AND FUME, NON-HALOGEN
PROCESSING GUIDE
To learn more about ECCOH wire and cable solutions, contact us
at +1.844.4AVIENT (1-844.428.4368)
www.avient.com
General Extrusion Guidelines
ECCOH™ compounds are thermoplastic polyolefin-based low smoke and fume, non-halogenated systems.
https://www.avient.com/sites/default/files/2020-07/phthalate-facts-brochure.pdf
PHTHALATES FACTS
PHTHALATES ARE KNOWN
TO BREAK DOWN IN THE
HUMAN BODY
Research has shown that after
entering the body, phthalate
are broken down into metabolites
within minutes and pass out
quickly in urine.2
PHTHALATE EXPOSURE
IS CONSIDERED LOW
Despite the fact that phthalates
are used in a wide range of
products, human exposure from
all sources is considered to be
extremely low.2
PHTHALATES ARE A USEFUL
CHOICE FOR HEALTHCARE
Flexible vinyl tubing does not
react with most medications,
allowing for reliable
administration of drugs, while
flexible vinyl bags prevent blood
contamination and extend shelf
life of the blood.3
PHTHALATES ARE
REGULATED
Based on earlier studies, a few
specific phthalates have been
banned for use in toys or other
items for sale to children
under twelve to reduce risk of
overexposure through hand-to-
mouth behaviors.
1 Source: chemicalsafetyfacts.org 2 Source: Centers for Disease Control and Prevention 3 Source: thisisplastics.com
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2020-07/core-powder-coatings-in-luxury-vehicles-case-study.pdf
Based on industry averages, a leather armrest typically
adds $30 to the cost of producing a single door, while
the approximate cost of a slush molded vinyl armrest is
about $10 per door.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Global%2520Engineered%2520Materials.pdf
Nikrant
Page 67
United
States
36%
Europe
36%
Canada
2%
Asia
20%
Latin
America
2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions
At a Glance
Global Specialty Engineered Materials
Appliance
6% Building &
Construction
3%
Wire & Cable
14%
Electrical &
Electronics
14%Consumer
21%
Packaging
5%
Industrial
8%
Misc.
3%
HealthCare
5%
Transportation
21%
America
6%
2011 Revenue by Industry Segment2011 Revenue by Industry Segment
1.1%
1.3%
3.4%
5.1%
9.6%
8.0%
12-16%
2006 2007 2008 2009 2010 2011 2015
Operating Income % of Sales
Target
Expanding ProfitsExpanding Profits
Page 68
Value Proposition
• GSEM is a global leader providing complete specialty solutions encompassing
innovative technologies and services to enable customer success
Transformation Highlights
• Dramatic turnaround of the Engineered Materials business through mix
improvement and specialty focus
Value Proposition and Transformation Highlights
Global Specialty Engineered Materials
improvement and specialty focus
• GLS acquisition successfully integrated, having more than
doubled earnings in 3 years
• PolyOne culture and strategy now engrained worldwide
• Expansion into healthcare with dedicated resources
> $15B Addressable Market
Page 69
• Polymer design, formulation and service expertise
• Broad, global technology base and regional centers
of excellence
• Ten innovation centers around the world
Key Differentiators
Global Specialty Engineered Materials
• Ten innovation centers around the world
• Specialty brand leadership with
PolyOne, GLS, NEU and ECCOH
• Ability to leverage global key
account team
Page 70
From Volume
Commodity-driven product portfolio
To Value
Specialty technology and solutions
EM North America Transformation
Volume Sales Gross Margin $
Mix Transformation – Executing the Strategy
Global Specialty Engineered Materials
2006 2011 2006 2011 2006 2011
Page 71
$12
$29
Operating Income
($ in millions)
• Provided access to new customers
in specialized, high-growth markets
such as healthcare and consumer
• Strategic partner to many of the
world’s best-known companies
GLS Integration Success
16.9%
8.2%
2007 2011
2007 2011
Working Capital % of Sales
• Complementary global footprint
provided additional cross-selling
opportunities
• Opportunity to expand margins
and drive working capital
improvement while remaining
customer-focused
Page 72
$1.3
$27.6
2006 2011
Healthcare Revenue
• Investment in dedicated
healthcare team to drive
penetration and growth
• Leverage product portfolio
globally & win specialty business
Areas of Focus
Global Specialty Engineered Materials
$10.5
$117.9
2006 2011
Consumer Revenue
2006 2011globally & win specialty business
in targeted markets
• Aggressively commercialize
specialty innovation platforms
• Utilize our innovation centers to
influence OEM design
(Revenue in $ millions)
Page 73
• Carbon Nanotube Formulations
� Applications: Semiconductor equipment, hard drives
� Customer benefits: Scrap cost reduction and
clean conductivity
• Thermally Conductive Solutions
Applications: Sockets and bulb holders for LED lighting
Key Innovations
Global Specialty Engineered Materials
� Applications: Sockets and bulb holders for LED lighting
� Customer benefits: Cost reduction, energy saving, and
design flexibility
• FDA-Regulated TPEs
� Applications: Food packaging seals, intravenous delivery
systems, medical stoppers, prefilled syringes
� Customer benefits: Clean and safe elastomers for highly
regulated applications
Page 74
Critical Imperatives and 2015 Goal
Global Specialty Engineered Materials
Critical Imperatives
• Commercialize critical new technology platforms
• Manage the mix as we continue to drive
the transformation
• Global translation of commercial successes
2015 Goal
• 12 - 16% return on sales
Page 75
Page 76
https://www.avient.com/sites/default/files/2020-11/gls-acqua-plose-case-study.pdf
When closurelogic
turned to Avient for material selection help, the team
developed a GLS™ TPE (thermoplastic elastomer) based
on a stable, low migration TPE with a lower processing
temperature compared to competitive TPEs, thus
resulting in even fewer volatiles.